{"id":"NCT01535560","sponsor":"Alcon Research","briefTitle":"Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa","officialTitle":"Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-04","primaryCompletion":"2012-10","completion":"2012-10","firstPosted":"2012-02-17","resultsPosted":"2013-12-10","lastUpdate":"2013-12-10"},"enrollment":589,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Otitis Externa"],"interventions":[{"type":"DRUG","name":"AL-60371, 0.3% otic suspension","otherNames":[]},{"type":"DRUG","name":"AL-60371 Vehicle","otherNames":[]}],"arms":[{"label":"AL-60371","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study was to demonstrate superiority of AL-60371 relative to Vehicle based on clinical cures at test-of-cure (TOC) for the treatment of acute otitis externa (AOE).","primaryOutcome":{"measure":"Proportion of Patients With Clinical Cures at the Day 11 (TOC) Visit","timeFrame":"Day 11","effectByArm":[{"arm":"AL-60371","deltaMin":68.7,"sd":null},{"arm":"Vehicle","deltaMin":40,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":274},"commonTop":[]}}